Sukhatme Mayukh bought ROIV
December 29, 2025 · Form 4 insider transaction
Sukhatme Mayukh bought 748,358 shares of Roivant Sciences Ltd. at $12.68 per share, a transaction worth $9.49M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
748,358
Price
$12.68
Total value
$9.49M
InsiderSukhatme Mayukh
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateDecember 29, 2025
Filing dateDecember 31, 2025
Shares owned after19,584,905
OwnershipDirect
10b5-1 planNo
AmendedNo